When Policy Lags Behind Science: Buprenorphine Dosing Reconsidered with Dr. Drits | Ep 5

Are dose caps on buprenorphine costing lives? In this episode of the Transform Mind Podcast, Dr. O and Dr. Drits dig into the evidence and the gaps around buprenorphine dosing for opioid use disorder In the fentanyl era, drawing on a 2023 narrative review by Grande and colleagues published in the Journal of Addiction Medicine.Higher doses are consistently linked to better treatment retention. Yet dose caps persist in clinical practice and insurance policy, even as the opioid supply has fundamentally shifted. Dr. O and Dr. Drits break down why, and what clinicians and patients can do about it.In this episode:→ Why the "ceiling effect" applies to respiratory depression not to craving or withdrawal relief→ What the evidence says about retention, fentanyl, and dosing→ How to advocate for patients within institutional and insurance constraints→ Common myths about diversion and high-dose buprenorphine→ Shared decision-making in practiceLearning ObjectivesBy the end of this episode, listeners will be able to:Describe the evidence base regarding buprenorphine dose limits and clinical outcomes.Explain how buprenorphine pharmacology informs safety at higher doses.Identify policy and systemic factors that influence dosing practices.Apply evidence-based reasoning to clinical and systems-level decision-making in opioid use disorder care.Chapters:00:00 High Dose Benefits 01:23 Podcast Intro Format02:34 Why Dose Caps Matter07:48 Guest Perspective Policy Lag11:27 Dose Limits Today14:44 Buprenorphine Pharmacology18:07 Retention Saves Lives20:31 Fentanyl Needs Higher Doses22:25 Advocacy Under Limits24:53 Training And Myths28:38 Case Dosing Decisions34:38 Shared Decision Making37:34 Ceiling Effect Explained39:24 Key Takeaways Reference: Grande LA et al. "High-dose buprenorphine for the treatment of opioid use disorder in the context of fentanyl exposure." Journal of Addiction Medicine, 2023.⚠️ This podcast is for educational purposes only and does not constitute medical advice. Clinical decisions should be made in consultation with a qualified healthcare provider.#BuprenorphineTreatment #OpioidUseDisorder #MOUD #FentanylCrisis #AddictionMedicine #HarmReduction #TransformMindPodcast